Official government records, as published. No commentary. Every entry links to its source.
Agencies › Federal Register document
2026-07-16 · Notice · Federal Register document 2026-14346

Government Owned Invention Available for License: Selective Expansion of Engineered TCR-T Cells for Use in Adoptive Cell Immunotherapy

Official abstract: The National Cancer Institute (NCI) seeks capable licensees interested in commercializing T cell receptor (TCR)-engineered T cells expressing murine/human hybrid receptors.